Breaking Down Xiamen Meiya Pico Information Co.,LTD. Financial Health: Key Insights for Investors

Peeling back the numbers on Xiamen Meiya Pico Information Co., Ltd. reveals a turbulent picture that investors can't ignore: Q1 2025 revenue plunged to ¥215.29 million, a staggering 75.30% quarter-on-quarter decline from ¥871.74 million, yet the company still posted a trailing twelve months revenue of ¥1,790,202,496 with a TTM gross profit of ¥623,098,944 (gross margin 34.8%) alongside a TTM net loss of ¥507,292,864 and a profit margin of -28.34%; operational strain is evident in an operating margin of -66.99% even as EBITDA stands at ¥221,287,326 (EBITDA margin ~12.34%), market capitalization sat at CN¥11.54 billion on July 1, 2025, valuation multiples show a trailing P/E of 273.83 and a forward P/E of 33.58, while projected 2024 net losses attributable to shareholders of ¥3.68-4.98 billion (and adjusted losses of ¥5.01-6.71 billion) plus absent debt and liquidity disclosures underscore the risks-set against R&D investment of RMB 200 million in 2023 (16.7% of revenues), strategic AI partnerships, and a management-forecasted 10% CAGR that frame potential upside if execution and market conditions align

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) Revenue Analysis

Key revenue and profitability indicators for Xiamen Meiya Pico Information Co.,LTD. highlight a mixed performance: solid trailing-twelve-month topline growth and gross margins, offset by a sharp quarter-to-quarter revenue contraction and a substantial TTM net loss.

• Q1 2025 revenue: ¥215.29 million - down 75.30% from Q4 2024's ¥871.74 million.
• TTM revenue: ¥1,790,202,496 - representing a 10.90% year-over-year increase.
• TTM gross profit: ¥623,098,944; gross profit margin: 34.8% (TTM).
• TTM net income: net loss of ¥507,292,864.
• Reported quarterly revenue growth figure referenced as 10.90% (context: TTM YoY growth), while sequential Q/Q shows the 75.30% decline - signaling volatility.

• Interpretation: TTM figures show revenue growth and respectable gross margin, but the large sequential revenue drop in Q1 2025 and sizable net loss raise concerns about recurring revenue stability and cost structure.
• Areas to monitor: quarter-to-quarter revenue recovery, margin sustainability, and progress toward reversing the TTM net loss.

Exploring Xiamen Meiya Pico Information Co.,LTD. Investor Profile: Who's Buying and Why?

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) Profitability Metrics

• Net profit margin (TTM): -28.34% - company is reporting a net loss relative to revenue.
• Operating margin (TTM): -66.99% - indicates substantial operating inefficiency and high operating costs relative to sales.
• Return on assets (ROA, TTM): -4.44% - assets are not generating positive returns.
• Return on equity (ROE, TTM): -13.13% - shareholders are experiencing negative returns on invested capital.
• EBITDA (TTM): ¥221,287,326 - positive EBITDA indicates cash-generation before interest, taxes, depreciation and amortization.
• EBITDA margin (TTM): ~12.34% - EBITDA as a share of revenue, showing core earnings capacity despite net losses.

• Implication: Positive EBITDA (~¥221M) provides a runway for restructuring but net and operating losses indicate urgent need to reduce overhead, improve gross margins, or address financing costs.
• Focus areas: cost structure normalization, operating-efficiency programs, and capital/interest expense management to convert EBITDA into net profitability.

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) - Debt vs. Equity Structure

Assessing the capital structure of Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) is constrained by limited disclosure of debt and equity line items in publicly available financial reports. Key observable datapoints and notable gaps are listed below.

• Market capitalization: CN¥11.54 billion (as of July 1, 2025).
• Debt-to-equity ratio: Not specified in available disclosures.
• Total debt: Not disclosed in the company's reported financial statements accessible to investors.
• Total equity: Specific figures not provided in the cited reports, preventing direct calculation of leverage.
• Implication: Absence of detailed debt/equity figures limits assessment of financial leverage, liquidity risk, and solvency metrics.
• Recommendation for investors: Seek additional disclosure or direct company reporting for a comprehensive capital-structure analysis.

For the company's stated guiding principles and broader strategic context, see: Mission Statement, Vision, & Core Values (2026) of Xiamen Meiya Pico Information Co.,LTD.

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) - Liquidity and Solvency

Assessment of Xiamen Meiya Pico Information Co.,LTD.'s short‑ and long‑term financial resilience is constrained by limited publicly available liquidity and solvency disclosures. The absence of core ratios and detailed debt/equity breakdowns prevents a definitive evaluation of its ability to meet obligations and withstand leverage stress.

• Current ratio: Not provided / N/A - unable to assess short‑term liquidity cushion.
• Quick ratio: Not provided / N/A - inability to judge immediate cash + receivables coverage absent inventory.
• Long‑term debt: Not disclosed in the examined materials - solvency position cannot be determined.
• Shareholders' equity: Not specified in the examined materials - leverage and coverage metrics cannot be calculated.

To illustrate the informational gap clearly, the table below summarizes available versus missing liquidity and solvency metrics as of the most recent reporting period reviewed.

• Implication: Without current and quick ratios, creditors' and investors' views on short‑term payment capacity are blind to working capital structure.
• Implication: Missing long‑term debt and equity numbers mean leverage, interest coverage, and solvency stress testing cannot be performed.
• Actionable data requests: full balance sheet with current assets/liabilities, breakdown of inventories and receivables, detailed schedule of long‑term borrowings, and consolidated shareholders' equity.

For further context on ownership, trading interest and investor composition that may affect liquidity risk perceptions, see: Exploring Xiamen Meiya Pico Information Co.,LTD. Investor Profile: Who's Buying and Why?

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) - Valuation Analysis

• Trailing P/E: 273.83 - extremely high, reflecting very low trailing earnings or a recent earnings trough vs. share price.
• Forward P/E: 33.58 - materially lower than trailing but still elevated versus typical sector norms.
• P/S: CN¥6.45 - investors paying a high premium per yuan of revenue.
• P/B: CN¥3.41 - implies market values the company well above book equity.
• EV/Revenue: 6.37 - signals a high enterprise valuation relative to sales.
• EV/EBITDA: -31.85 - negative because EBITDA or adjustments are negative, producing a misleadingly large negative multiple.
• DCF intrinsic value: CN¥-6.35 - model output negative, indicating current cash-flow profile or assumptions produce no positive intrinsic per-share valuation.
• Peter Lynch fair value: CN¥-2.95 - another fundamental approach suggesting overvaluation relative to current market price.

• Interpretation: Market multiples (P/E, P/S, P/B, EV/R) are substantially above industry averages, indicating strong investor growth expectations or speculation.
• Warning signs: Negative EV/EBITDA and negative DCF/Peter Lynch valuations imply current operating profitability and free cash flow are weak or negative, making standard multiple comparisons less reliable.
• Volatility drivers: High trailing P/E versus materially lower forward P/E suggests earnings recovery is expected; reconciliation depends on management guidance and near-term margin improvement.

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) Risk Factors

• 2024 forecast: net loss attributable to shareholders of ¥3.68 billion to ¥4.98 billion.
• 2024 forecast after deducting non-recurring gains/losses: net loss of ¥5.01 billion to ¥6.71 billion.
• Projected losses of this magnitude materially increase solvency and going-concern risk if not reversed by substantial operational or financing improvements.
• Company performance has been volatile, with multiple reporting periods showing substantial losses, amplifying uncertainty over near-term recovery prospects.
• Lack of detailed, transparent debt and covenant information hinders assessment of liquidity and refinancing risk.
• Investors should consider heightened downside risk and reduced margin for error in operational execution or capital access.

• Potential triggers that would materially change risk profile: equity or debt capital injections, asset disposals, major contract wins, or credible restructuring plans.
• Absent clear, verifiable remedies or improved disclosure of liabilities and cash runway, downside risk remains significant.

Xiamen Meiya Pico Information Co.,LTD. (300188.SZ) - Growth Opportunities

• 2023 R&D spend: RMB 200.0 million (representing 16.7% of 2023 total revenues).
• Implied 2023 revenues: ~RMB 1,197.6 million (derived from R&D share).
• Management target: 10% CAGR over the next five years, focused on healthcare, finance and education.
• Strategic partnerships with multiple universities and research institutions to accelerate AI research and commercialization.
• Ongoing digital transformation and big-data analytics initiatives intended to expand addressable market and product depth.

• Commercializing AI R&D into product lines (AI-enabled threat detection, data governance, analytics platforms).
• Scaling partnerships with universities and research institutes to shorten time-to-market for advanced models and domain-specific solutions.
• Cross-selling digital transformation services into existing enterprise accounts in healthcare and finance where regulatory and data-security needs align with the company's capabilities.
• Leveraging increased R&D intensity (16.7% of revenue in 2023) to build differentiated IP and SaaS revenues that improve long-term margins.

• R&D conversion rate - ability to convert RMB 200M R&D into commercial products and recurring revenue at scale.
• Market adoption timing for AI/big-data solutions in targeted verticals and competitive dynamics from large cloud and security vendors.
• Partnership outcomes - research ties must yield prototypes, pilots and paying customers to justify elevated R&D intensity.
• Macroeconomic and regulatory factors in China and key overseas markets that could affect procurement cycles in healthcare and finance.